Beyond MVP: Scaling UX Strategy for Growing HealthTech Startups

Martin Sandhu
Martin Sandhu

July 2025

What happens to UX when your healthtech startup outgrows its MVP?

Early on, UX is scrappy: a designer (or a founder) works closely with engineers, decisions happen in Slack, and everyone “just knows” the user. That’s fine for getting a minimum viable product out the door.

But as you grow—more users, more features, more teams—that informal model breaks down. UX debt grows, interfaces fragment, and every new feature feels harder to design and ship. Clinicians and patients start to feel that fragmentation too.

Scaling UX isn’t about making things prettier. It’s about making design reliable, repeatable, and aligned with your strategy as complexity increases.

How do you know it’s time to evolve your UX strategy?

A few warning signs:

  • Different teams are shipping UI that “feels” different.
  • You’re re-solving the same design problem in multiple places.
  • Onboarding new designers or engineers takes a long time.
  • Stakeholders complain that the product feels cluttered or inconsistent.
  • UX work is always reactive, rarely strategic.

If any of that sounds familiar, you’ve moved beyond “just an MVP” and into a stage that needs more structure.

What are the pillars of a scalable UX strategy?

There’s no one-size blueprint, but most growth-stage healthtech teams benefit from investing in:

  1. A design system, not just a component library
    A design system is more than buttons and colors—it includes patterns, usage guidelines, content principles, and examples specific to your domain (e.g., how you display vitals, how you show risk, how alerts behave).
  2. A structured research function
    You can’t talk to every user anymore, but you still need their voice. That means dedicated UX researchers, standardized study templates, and a regular cadence of discovery and evaluative research.
  3. Cross-functional UX governance
    Agreements on who can change what, how design decisions are documented, and how trade-offs (clinical, technical, regulatory) are made.
  4. Clear UX ownership at product-line or domain level
    As you expand, each major area (e.g., clinician console, patient app, admin tools) needs someone accountable for the coherency of that experience.

How can you keep clinicians and patients at the center as you scale?

Growth often introduces distance: suddenly you’re selling to new markets, new specialties, new geographies. The risk is designing from assumptions again.

Guardrails to avoid that:

  • Panel-based research – maintain ongoing relationships with a panel of clinicians and patients you can regularly tap for feedback.
  • Continuous discovery – embed small, frequent research activities into sprints rather than relying only on big, occasional studies.
  • Practice-level context – don’t just test screens; observe workflows in situ where possible (clinic, telehealth, home use).

In regulated health, you also need to maintain documentation of user needs and usability evidence—not just for design quality, but for regulators and buyers. Scaling UX includes scaling that evidence trail.

How does UX collaborate with product, engineering, and regulatory at scale?

As the organization grows, silos tend to form. The cure is intentional integration:

  • Joint planning – UX, product, engineering, and regulatory involved in quarterly / release planning.
  • Shared artifacts – requirements, user needs, and design decisions accessible and traceable across tools.
  • Design reviews that aren’t just aesthetics – reviewing flows, risk, edge cases, and operational impact, not just how things look.

For MedTech in particular, this is where UX’s role in human factors, risk mitigation, and evidence generation becomes more central. You’re not just designing the interface; you’re designing part of the safety case.

What’s the payoff of scaling UX deliberately?

Done well, a scaled UX strategy gives you:

  • Faster, more consistent feature delivery
  • Less cognitive load for users as your product grows
  • Clearer evidence for buyers, regulators, and partners
  • A stronger brand in a crowded market
  • A team that can sustain innovation without burning out

Going beyond MVP doesn’t mean abandoning the agility that got you here. It means giving your UX practice the structure it needs to keep pace with your ambition.

Like this?

More

HealthTech

insights

View more insights

Contact us

Let’s talk

We create human-centered solutions that drive positive outcomes for users and organisations. Let’s collaborate.

See our work
nuom
Typically replies in a few hours
nuom
Hi there!
How can we help you today?
Start Whatsapp Chat
WhatsApp icon